Yes, great post Petemantx. I dove in ADXS at about the same time as I did IPIX, 3 or more years ago. ADXS paid its top Execs strong multiples of what Leo has made, lent the company nothing, dropped some uses because they did not see what the data implied early enough, and blew threw a couple of hundred million and still not one FDA 2b or 3. The science is still strong, none the less, but ADXS remains mostly a one trick pony, but with multiple uses. My IPIX bets (investments?) now equal my total in ADXS, but there are 5 or 6 or more very strong shots on goal here, and one there. Just saying.